Tolerability of a novel chemoradiotherapy (CRT) protocol in the adjuvant treatment of the gastric cancer
A Maráz, O Fazekas, G Uhercsák, E Valicsek, A Nikolényi, L Torday, M Lázár, Z Varga, Z Nagy, E Szil, K Hideghéty, Z Kahán, L Thurzó · Zeitschrift für Gastroenterologie · 2008 · Heft 05
Bibliografische Angaben
Zusammenfassung
Earlier data suggested that pts with T3-T4 and/or N1 stage gastric cancer, the adjuvant CRT (Macdonald protocol) significantly increased the relapsus-free and overall survival, although the method was not popular because of the difficulties of planning of the radiotherapy (RT) and high rates of side effects. The aim of this study was to evaluate the tolerabilitiy of this CRT in our practise. Patients, method: We analysed the toxicity and the dose distribution of 32 pts, age 59(39–78). All pts underwent surgery (22 total, 10 partial gastrectomy). Histology revealed 13 adeno-, 6 sigillocell. carcinomas, 8 diffuse…
